Pilar Retamar Gentil

Profesora Asociada CIS
pretamar@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin Grupo
Tipo Año Título Fuente
Artículo2022 "Pseudomonas aeruginosa" Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development-Results from the PRO-BAC Cohort Antibiotics
Artículo2022 Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP Enfermedades infecciosas y microbiología clínica
Artículo2022 Autoantibodies against type I IFNs in patients with critical influenza pneumonia. JOURNAL OF EXPERIMENTAL MEDICINE
Revisión2022 Compatibility of prolonged infusion antibiotics during Y-site administration Nursing in Critical Care
Artículo2022 Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia MICROORGANISMS
Artículo2022 Effectiveness of fosfomycin for the treatment of multidrug-resistant escherichia coli bacteremic urinary tract infections: a randomized clinical trial JAMA Network Open
Short Survey2022 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) CLINICAL MICROBIOLOGY AND INFECTION
Artículo2022 Management of Patients with Suspected or Confirmed Antibiotic Allergy. Executive Summary of Guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC). JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY
Editorial2022 Predicting bacteremia in the Emergency Room: How and why Enfermedades infecciosas y microbiología clínica
Artículo2022 Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain FRONTIERS IN PHARMACOLOGY
Artículo2022 Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project. MICROBIOLOGY SPECTRUM
Artículo2022 Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial CLINICAL MICROBIOLOGY AND INFECTION
Nota2022 Unneeded antibiotics for acute respiratory infections in primary care: stop as early as possible CLINICAL MICROBIOLOGY AND INFECTION
Resumen congreso2021 Antimicrobial stewardship program implementation during the global pandemic of coronavirus disease (COVID-19) INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
Artículo2021 Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score THORAX
Artículo2021 Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade CLINICAL MICROBIOLOGY AND INFECTION
Artículo2021 Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021 Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study LANCET INFECTIOUS DISEASES
Editorial2021 Preface JAC-antimicrobial resistance
Artículo2021 Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results NEW ENGLAND JOURNAL OF MEDICINE
Artículo2021 Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial BMJ OPEN
Corrección2020 Author Correction: A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance (Nature Microbiology, (2019), 4, 7, (1160-1172), 10.1038/s41564-019-0410-0) NATURE MICROBIOLOGY
Artículo2020 Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis LANCET INFECTIOUS DISEASES
Artículo2020 Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project BMJ OPEN
Artículo2019 A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance NATURE MICROBIOLOGY
Artículo2019 Executive summary of outpatient parenteral antimicrobial therapy: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society Enfermedades infecciosas y microbiología clínica
Artículo2019 Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study CLINICAL INFECTIOUS DISEASES
Artículo2019 Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: Study protocol for a cluster-randomised crossover trial, the NO-BACT study BMJ OPEN
Artículo2019 Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to Gram-negative bacteria DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Editorial2019 Un paso adelante en la definición de indicadores PROA: medir bien para trabajar mejor FARMACIA HOSPITALARIA
Artículo2018 A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients CLINICAL MICROBIOLOGY AND INFECTION
Artículo2018 Análisis de la calidad de uso de antimicrobianos en el servicio de urgencias de un hospital de tercer nivel EMERGENCIAS
Artículo2018 Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Artículo2017 Concordance of Barthel Index, ECOG-PS, and Palliative Performance Scale in the assessment of functional status in patients with advanced medical diseases BMJ SUPPORTIVE & PALLIATIVE CARE
Artículo2017 Oral anticoagulation in patients with atrial fibrillation and medical non-neoplastic disease in a terminal stage INTERNAL AND EMERGENCY MEDICINE
Artículo2017 Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial BMJ OPEN
Revisión2016 Escherichia coli: an old friend with new tidings FEMS MICROBIOLOGY REVIEWS
Artículo2015 Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology Enfermedades infecciosas y microbiología clínica
Artículo2015 Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) Enfermedades infecciosas y microbiología clínica
Artículo2015 Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia? JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014 Development of a Six-Month Prognostic Index in Patients With Advanced Chronic Medical Conditions: The PALIAR Score JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Artículo2014 Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2013 Anticoagulación en pacientes pluripatológicos con fibrilación auricular MEDICINA CLINICA
Artículo2013 Evaluating the quality of antimicrobial prescribing: Is standardisation possible? Enfermedades infecciosas y microbiología clínica
Artículo2013 Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-beta-Lactamase-Producing Escherichia coli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013 Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study BMC INFECTIOUS DISEASES
Artículo2013 Recalibración del Palliative Prognostic Index en pacientes con enfermedades médicas avanzadas REVISTA CLINICA ESPANOLA
Artículo2013 Reliability of a short questionnaire for the diagnosis of severe disability in polypathological patients attended in hospital setting EUROPEAN JOURNAL OF INTERNAL MEDICINE
Artículo2012 Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based Analysis ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts CLINICAL INFECTIOUS DISEASES
Revisión2010 Current management of bloodstream infections EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Artículo2010 Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals CLINICAL MICROBIOLOGY AND INFECTION
Artículo2010 Headache and blurred vision in a 26 years old woman MEDICINA CLINICA

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2012 31/12/2014 Investigador/a Interacción de mecanismos plasmídicos y cromosómicos de resistencia a quinolonas en escherichia coli y su efecto en la resistencia, fitness, toxicidad celular y expresión en biocapas (PI11/00934) Ministerio de Ciencia e Innovación (Instituto de Carlos III) (Nacional)
El investigador no tiene ningún resultado de investigación asociado